Table 6. Comparison of baseline data of CTCs interstitial <1 and ≥1 (classification data).
| Type | Sex (male/female) | Age (<45/≥45 years) | BCLC staging (A/B/C staging) | Number of tumors (equal to 1/>1) | Size of tumors (≤5/>5 cm) | Envelope (complete/ incomplete) |
Envelope invasion (complete/ incomplete) |
Microvascular tumor thrombus (with/without) | Child-Pugh classification (A/B/C level) | Portal vein tumor thrombus (with/without) | AFP ≤400/>400 ng/mL | Hepatitis B (<5×10e2/≥5×10e2) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interstitial CTCs<1 | 41/7 | 23/25 | 17/15/16 | 36/12 | 13/35 | 16/19/13 | 33/15 | 20/28 | 46/2/0 | 14/34 | 20/28 | 16/32 |
| Interstitial CTCs ≥1 | 44/7 | 21/30 | 12/17/22 | 29/22 | 9/42 | 19/23/9 | 31/20 | 27/24 | 47/3/0 | 20/31 | 18/33 | 20/31 |
| χ2 | 0.015 | 0.455 | 1.845 | 3.607 | 1.274 | 1.276 | 0.687 | 1.260 | 0.170 | 1.107 | 0.425 | 0.370 |
| P value | 0.903 | 0.500 | 0.397 | 0.058 | 0.259 | 0.528 | 0.407 | 0.262 | 0.680 | 0.293 | 0.515 | 0.543 |
CTC, circulating tumor cell; BCLC, Barcelona clinic liver cancer; AFP, alpha-fetoprotein.